Hanta, I. Et Al. 2018. The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis. International Conference of the American-Thoracic-Society , (California, United States Of America).

Hanta, I., Cilli, A., SEVİNÇ, C., Dirol, H., & Kuleci, S., (2018). The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis . International Conference of the American-Thoracic-Society, California, United States Of America

Hanta, I. Et Al. "The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis," International Conference of the American-Thoracic-Society, California, United States Of America, 2018

Hanta, I. Et Al. "The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis." International Conference of the American-Thoracic-Society , California, United States Of America, 2018

Hanta, I. Et Al. (2018) . "The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis." International Conference of the American-Thoracic-Society , California, United States Of America.

@conferencepaper{conferencepaper, author={I. Hanta Et Al. }, title={The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients with Idiopathic Pulmonary Fibrosis}, congress name={International Conference of the American-Thoracic-Society}, city={California}, country={United States Of America}, year={2018}}